Here are relevant reports on : companion-diagnostics-market
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Veterinary PoC Diagnostics Market by Product (Imaging Systems, Analyzers, Reagents), Technology (Immuno & Molecular Diagnostics), Application (Pathology, Bacteriology, Gynecology), Animal (Cat, Dog, Horse, Cattle), End User & Region - Global Forecast to 2025
The global veterinary PoC diagnostics market growth is primed to transition from $1.4 billion in 2019 to $2.4 billion by 2025, showcasing a strong CAGR of 8.9%. Key drivers include the rising prevalence of zoonotic diseases in animals and the need for rapid diagnostics, though high costs of imaging equipment pose a challenge.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Noninvasive Cancer Diagnostics Market by Instruments (Solid Tumor, Blood Cancer, Lung Cancer, Breast Cancer), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics) - Analysis & Global Forecast to 2019
The global non-invasive cancer diagnostic market is expected to show considerable growth during the forecast period. This is attributed to growing cancer cases worldwide, especially breast and lung cancer. In 2013, in the U.S. there were more than 1,660,290 new cases of all type of cancers diagnosed in 2013 (American Cancer Society). Increased healthcare expenditure and increase research and development activities are some of the other factors driving the growth of this market. However factors such as high cost of treatment, and stringent regulatory guidelines are limiting the market growth.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Animal Health Market by product (Parasiticides (Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive( Vitamin, Amino Acids, Antioxidant), Growth Promoter) Animal (Livestock, Companion), End-user (Hospitals) & Region - Global Forecast to 2025
The global Asia Pacific Animal Health Market in terms of revenue was estimated to be worth $15.6 billion in 2020 and is poised to reach $22.1 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027
Veterinary pain management market growth is primed to transition from $1.8 billion in 2022 to $2.5 billion by 2027, showcasing a strong CAGR of 6.7%. Factors such as growth in companion animal adoption, the increasing number of veterinary practitioners and their rising income levels in developed economies, increasing consumption of meat & milk, the growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of this market.
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Veterinary Rapid Test Market by Product (Rapid Test Kit, Rapid Test Readers), Application (Viral, Bacterial, Parasite, Allergies), and Animal Type (Companion (Cat, Dog, Horse), Livestock (Cattle, Swine, Poultry)) - Global Forecast to 2024
The global veterinary rapid tests market is projected to reach USD 854 million by 2024 from USD 573 million in 2019, at a CAGR of 8.3%. Factors contributing to the growth of this market include the increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases. The prominent players in this market are Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Biopanda Reagents Ltd. (UK), Fassisi GmbH (Germany), Virbac (France), BioNote, Inc. (South Korea), SWISSAVANS AG (Switzerland), MEGACOR Diagnostik GmbH (Austria), and Woodley Equipment Company (UK).
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) - Forecasts to 2023
The veterinary X-ray market is projected to reach USD 872 million by 2023, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The US veterinary vaccines market, valued at US$4.39 billion in 2025, stood at US$4.67 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of US$6.50 billion by the end of the period. This growth is attributed to the increasing awareness regarding animal health as well as the rising pet population and pet ownership. Other emerging trends affecting the growth of this segment are government initiatives to improve the health of animals and increased adoption of pet coverage.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The Europe veterinary vaccines market, valued at US$3.84 billion in 2025, stood at US$4.08 billion in 2026 and is projected to advance at a resilient CAGR of 6.6% from 2026 to 2031, culminating in a forecasted valuation of US$5.61 billion by the end of the period. The growth of the market is driven by the increased pet ownership and greater emphasis on animal welfare.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Telemedicine Market by Type (Telephone, Internet), Component (Software & Services, Hardware), Application (Diagnosis & Treatment, Prescription, Follow-up, Consultation, Education), Animal Type (Companion, Livestock) & Region - Global Forecast to 2028
The global veterinary telemedicine market, valued at US$457 million in 2022, stood at US$530 million in 2023 and is projected to advance at a resilient CAGR of 18.3% from 2023 to 2028, culminating in a forecasted valuation of US$1,230 million by the end of the period. Growth in this market is largely driven by the increasing adoption of Internet of Things (IoT) and Artificial Intelligence (AI) technologies both pet owners and the veterinary industry has significantly influenced the development and effectiveness of veterinary telemedicine.
- Published: August 2023
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
